Clinical trials
Early Diagnosis clinical trials
Below are recruiting early diagnosis clinical trials, each written for real people, not researchers. We’re tracking 109 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06937112Recruiting
A new scan for early detection of certain cancers
This trial tests a new imaging agent (18F-FAPI) to see if it can help find tumors early in people with lung, thyroid, pancreatic, melanoma, or neuroendocrine cancers.
Nanjing, JiangsuAges 18–75 - NCT06875739Enrolling by invitation
Saliva test for early diagnosis of brain diseases
This study tests whether a saliva sample can help tell the difference between brain diseases like Alzheimer's, Parkinson's, and related conditions. By using a special laser technique, researchers hope to find a quick, non-invasive way to make an earlier and more accurate diagnosis.
CagliariAges 60–85 - NCT07596147Recruiting
Early Movement Training for At-Risk Infants
This trial tests an early intervention program called SAFE for babies aged 3–12 months who had complications at birth or were born prematurely. The goal is to help their brain and movement development through specialized therapy.
Ankara, AnkaraAges 3 months–1 year - NCT07749417Recruiting
Detecting kidney injury early after heart procedures
This study tests a new light-based method to check kidney function right after heart surgery or imaging tests that use contrast dye. It aims to catch kidney damage early, so doctors can treat it sooner.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06978660Recruiting
AI-powered ECG test for early cardiac amyloidosis
This trial tests if an AI can spot early signs of cardiac amyloidosis from a standard 10-second ECG. If successful, it could lead to faster diagnosis and treatment.
Evanston, IllinoisAges 18 years+ - NCT06605053Recruiting
Improving HIV care for pregnant teens and young women in Tanzania
This trial aims to improve HIV prevention and treatment for pregnant adolescents and young women in Tanzania. It includes reviewing medical records, talking to patients and providers, and testing new care approaches.
Dar es SalaamAges 15 years+ - NCT03152630Recruiting
Vascular dementia check-up and risk diagnosis study
This study aims to find early ways to diagnose “vascular dementia,” which happens when blood vessel problems affect thinking and memory. It may help by testing how well certain health risk factors and medical information can predict who might be developing it.
TaipeiAges 65 years+ - NCT05663008Recruiting
Testing nerve-to-muscle signal changes to diagnose movement diseases
This study measures how nerves communicate with muscles, using recordings and gels. It aims to spot early, personalized signs of conditions like ALS and related diseases, and to improve diagnosis.
Dublin, LeinsterAges 18 years+ - NCT05919342Recruiting
Screening for early heart failure in primary care or at home
This trial tests whether simple screening using a blood test (natriuretic peptides) plus an ultrasound of the heart (echocardiogram) can find early heart failure sooner. Finding it earlier may help doctors start the right management to prevent it from getting worse.
Cleveland, OhioAges 40 years+ - NCT06283797Recruiting
Automated insulin early after type 1 diabetes diagnosis in kids
This trial tests whether starting automated insulin therapy soon after diagnosis helps children and teens with type 1 diabetes control their blood sugar better. It uses a system that automatically adjusts insulin delivery based on continuous glucose monitoring.
AngersAges 2–18 - NCT07693816Recruiting
Finding stroke caused by small artery disease
This study looks at whether your stroke was caused by branch atheromatous disease (BAD), a type of small artery blockage. Knowing this may help choose the best treatment and prevention plan.
BeijingAges 18–80 - NCT07680335Recruiting
Blood test to help diagnose Alzheimer's earlier
This study is testing whether a simple blood test can help doctors diagnose Alzheimer's disease earlier and more accurately. It's for people who are having memory or thinking problems and are visiting a memory clinic.
Amsterdam, North HollandAges 55 years+ - NCT07614594Recruiting
Urine Test to Detect Bladder and Kidney Cancer
This study tests whether a simple urine test can accurately identify cancer in the bladder, ureters (tubes between kidneys and bladder), or renal pelvis (part of the kidney). You would provide urine samples before your planned surgery, and researchers will compare the urine test results to your actual tissue diagnosis after surgery.
Zhengzhou, HenanAges 18 years+ - NCT07370077Recruiting
Early screening for lung nodules with breath, blood, and CT scans
This trial uses a new, non-invasive way to screen for lung cancer by combining your breath, blood, and CT scan images. The goal is to figure out whether a nodule found on a CT scan is cancerous or not, which could help patients avoid unnecessary procedures.
Beijing, Beijing MunicipalityAges 18 years+ - NCT03791034Recruiting
Blood DNA test to guide treatment in early lung cancer
This trial studies a “cell-free DNA” blood test to help diagnose and guide treatment decisions for early non-small cell lung cancer. It may help doctors tailor care based on genetic signals seen in the blood before and around surgery.
SeoulAges 18–90 - NCT06656728Recruiting
Simplifying cancer screening with a new tool
This trial tests a new screening tool that helps doctors find cancer. It involves completing medical exams and questionnaires. The study is for people who have not had cancer in the last 5 years.
Tel AvivAges 40 years+ - NCT07081724Recruiting
Early help program for toddlers waiting for autism diagnosis
This program offers early support for children aged 16 to 48 months who are waiting for an autism evaluation. It focuses on providing helpful strategies and activities while families wait for a formal diagnosis.
Philadelphia, PennsylvaniaAges 1.3 years–4 years - NCT05847855Recruiting
Blood test to help detect certain early pancreatic tumors
This study looks at a special analysis of your blood (called cfDNA fragmentomics) to help find and tell apart certain early pancreatic tumors. If you’re having surgery for one of the listed solid pancreatic tumors, this trial may use your blood samples to improve diagnosis.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06355245Recruiting
Early cancer detection study for unexplained symptoms
This study looks for early signs of cancer in people who have unexplained symptoms like extreme tiredness, weight loss, fever, or abnormal lab tests. You will be monitored and tested to see if markers can find cancer sooner.
StockholmAges 18 years+ - NCT07552584Recruiting
Blood test to screen for early lung cancer in COPD patients
This study uses an AI-powered blood test to identify people at high risk for lung cancer early, before symptoms appear. You'd be helping researchers see if this blood test can catch lung cancer sooner in people with COPD who have a smoking history.
VejleAges 50 years+ - NCT07124754Recruiting
Predicting lymph node spread in early stomach cancer
This study tests if artificial intelligence can predict whether early-stage stomach cancer has spread to lymph nodes. It also evaluates how well doctors assess the cancer. If the technology works, it could help guide treatment decisions.
Shijiazhuang, None SelectedAges 18 years+ - NCT06446882Recruiting
HER2DX test to guide treatment for early HER2+ breast cancer
This trial tests whether a new test (HER2DX) can help doctors choose the best treatment combination for HER2-positive breast cancer before surgery. It's for people whose cancer hasn't spread and who haven't started therapy yet.
GrazAges 18 years+ - NCT06389448Recruiting
Comparing Two Imaging Methods for Stomach Lesion Diagnosis
This trial compares two special camera methods (pCLE and EB) used during endoscopy to better see and diagnose early stomach changes. It may help doctors decide the best treatment for precancerous spots or very early cancer.
Wuhan, HubeiAges 18–75 - NCT06352320Recruiting
Improving care for cardiomyopathy patients
This trial aims to better understand and treat cardiomyopathy by studying patients' hearts with advanced tests. It seeks to find new ways to prevent or manage the condition early.
Xi'an, ShaanxiAges 18–80
Hear when a new Early Diagnosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for early diagnosis?
- Yes. Clin2 currently lists 109 recruiting early diagnosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a early diagnosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a early diagnosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.